Hostname: page-component-78c5997874-4rdpn Total loading time: 0 Render date: 2024-11-15T07:24:19.479Z Has data issue: false hasContentIssue false

Marginal selenium status in northern Tasmania

Published online by Cambridge University Press:  27 April 2011

Jeffrey M. Beckett*
Affiliation:
School of Human Life Sciences, University of Tasmania, Locked Bag 1320, Launceston, TAS7250, Australia
Madeleine J. Ball
Affiliation:
School of Human Life Sciences, University of Tasmania, Locked Bag 1320, Launceston, TAS7250, Australia
*
*Corresponding author: Dr J. M. Beckett, fax +61 3 63243658, email [email protected]
Rights & Permissions [Opens in a new window]

Abstract

Se plays many important roles in humans. Marginal Se status has been associated with adverse health effects including an increased risk of chronic disease such as cancer. There are few Australian data, but the population of Tasmania, Australia, is potentially at risk of marginal Se status. A cross-sectional study of 498 men and women aged 25–84 years was undertaken to assess the Se status of the northern Tasmanian population. Se status was assessed using dietary estimates and measures of serum Se and glutathione peroxidase (GPx). Mean Se intakes were 77·4 (sd 31·3) and 65·1 (sd 23·7) μg/d for men and women, respectively; 27 % of the subjects consumed less than the Australian/New Zealand estimated average requirement. Mean serum Se concentration was 89·1 (sd 15·1) μg/l; 83 % of the study subjects had serum Se concentrations below 100 μg/l and 60 % had serum Se concentration below 90 μg/l, suggesting that Se status in many subjects was inadequate for maximal GPx activity. This was supported by the positive association between serum Se and serum GPx (P < 0·001), indicating that enzyme activity was limited by Se concentrations. The lowest mean serum Se concentrations were observed in the oldest age ranges; however, the prevalence of marginal Se status was similar across age ranges and did not appear to be influenced by sex or socio-economic status. The prevalence of marginal Se status was high in all sex and age subgroups, suggesting that the northern Tasmanian population could benefit from increasing Se intakes.

Type
Full Papers
Copyright
Copyright © The Authors 2011

Se is an essential component of at least twenty-five selenoproteins in humans. These proteins include the glutathione peroxidase (GPx), iodothyronine deiodinase and thioredoxin reductase enzyme families, which play important roles including antioxidant protection and thyroid metabolism(Reference Moghadaszadeh and Beggs1, Reference Reeves and Hoffmann2). Se also appears to be important for immune function(Reference Broome, McArdle and Kyle3) and inflammatory response(Reference Curran, Jowett and Elliott4).

Populations in most regions of the world consume sufficient Se to avoid diseases associated with overt deficiency such as Keshan disease and Kashin–Beck disease(Reference Combs5, Reference Rayman6). However, it has been suggested that in many countries, based on estimated frequencies of low plasma or serum Se concentrations, 50 % or more of the population could have nutritional Se deficiency(Reference Combs5), which may have adverse effects on health.

There have been a number of studies on the effect of marginal Se status on health and the potential benefits of increasing Se status(Reference Rayman6), and attention has centred on associations with cancer. Associations between lower Se status and increased cancer incidence were first observed in geographical studies in the USA and China(Reference Clark, Cantor and Allaway7, Reference Kneller, Guo and Hsing8). Results from a number of case–control and intervention studies(Reference Wei, Abnet and Qiao9Reference Mark, Qiao and Dawsey16) have supported these findings, but not all have done so(Reference Mannisto, Alfthan and Virtanen17Reference Wallace, Byers and Morris19), and the only large randomised controlled trial, to date, has failed to detect a protective effect(Reference Lippman, Klein and Goodman20).

Se status of the population is primarily influenced by the Se content of food supply, which is directly related to the Se levels in soils on which crops and livestock are raised. Low Se status of the population has been reported in areas with low soil Se in New Zealand, Europe and certain provinces of China(Reference Combs5). In Tasmania, the southernmost state of Australia, most farming districts have experienced Se deficiency in livestock(Reference Mason, Richards and Stewart21), and, as a result, the human population is considered to be at risk of suboptimal Se status.

Studies of Se status in human populations in Tasmania have so far been very limited and have provided conflicting results(Reference McGlashan, Cook and Melrose22Reference Daniels, Gibson and Simmer24). The objective of the present study was to assess the Se status of a sample of the northern Tasmanian population.

Subjects and methods

The present study was cross-sectional in design. Recruitment was via mail, from an extract of the Australian electoral roll provided by the Australian Electoral Commission. The sample consisted of 192 men and 306 women residing in north, northwest and northeastern Tasmania. Subjects were 25–84 years old, free from significant illness and selected from the Australian Bureau of Statistics, Statistical Local Areas that were close to phlebotomy centres. The region in northern Tasmania from which the sample was drawn has a population of 126 958 residents >25 years of age, 52 % of whom are female and 40 % aged 55–84 years.

Subjects completed questionnaires to collect demographic, anthropometric and lifestyle information. A semi-quantitative FFQ was used to collect dietary data. Se intakes were calculated from responses using Nutrient Data Table (NUTTAB) 2006 food content values(25). Subjects attended phlebotomy centres in their local area to provide a venous blood sample, which was collected into trace element-free serum and serum separation vacutainer tubes (SST; Becton Dickinson, Rutherford, NJ, USA). Socio-economic status of subjects was estimated using the socio-economic indexes for areas (SEIFA) index for the area (Australian Bureau of Statistics Collector District) where each subject resided. The SEIFA index was derived from Australian Census variables related to both advantage and disadvantage, including households with low or high income, unemployment rates and proportions of people with limited or higher education(26). A lower SEIFA score in a given census district indicates that the district is relatively disadvantaged compared with the one with a higher score.

The present study was conducted according to the guidelines laid down in the Declaration of Helsinki, and all procedures involving human subjects were approved by the Human Research Ethics Committee (Tasmania). Written informed consent was obtained from all subjects.

Procedures

Following venepuncture, blood samples were separated within 24 h by refrigerated centrifugation for 15 min at 1335 g. Aliquots of serum were stored at − 80°C until analysis. All laboratory glassware, consumables and storage vessels used for trace element analysis were washed with 1 % HNO3 before use.

Serum Se concentration was determined by Zeeman-corrected graphite furnace atomic absorption spectrometry using a Spectra 640Z spectrophotometer (Varian, Inc., Palo Alto, CA, USA), and by the method of Saeed et al. (Reference Saeed, Thomassen and Langmyhr27). Analysis of Seronorm Trace Elements control serum (Sero, Billingstad, Norway) with a certified Se concentration of 72·6 μg/l gave a mean of 69·5 μg/l (CV 7·0 %; n 19). Intra-assay precision was 3·7 % (n 15).

Serum GPx was analysed on the DataPro clinical analyser (Thermo Electron Corporation, Melbourne, VIC, Australia) using a commercial reagent (Ransel; Randox Laboratories Limited, Crumlin, County Antrim, UK) based on the coupled enzyme assay by Paglia & Valentine(Reference Paglia and Valentine28). Inter- and intra-assay precision was 4·3 % (n 21) and 3·0 % (n 14), respectively.

Analysis for total antioxidant status (TAS) was performed on the DataPro clinical analyser (Thermo Electron Corporation) using the TAS reagent kit (NX2332; Randox Laboratories Limited). This method measured inhibition of the formation of the 2,2′-azinobis-(3-ethylbenzothiazoline-6-sulfonic acid) radical ABTS+, the level of which was proportional to the concentration of antioxidants in the sample. Randox TAS control serum was used for quality control; inter- and intra-assay precision was 2·8 % (n 17) and 2·8 % (n 20), respectively.

Serum total cholesterol, HDL-cholesterol, LDL-cholesterol and TAG were measured on the DataPro clinical analyser using standard enzymatic kits (Thermo Electron Corporation). Inter (n 17)- and intra (n 11)-assay precision for all serum lipid analyses was < 4 %.

Statistical analysis

Differences in Se status within groups as defined by age, sex or smoking habit were estimated using general linear modelling (STATA version 9.2; StataCorp LP, College Station, TX, USA). Post-estimation Holm's test analysis was then used to adjust P values for multiple comparisons(Reference Aickin and Gensler29). The relationship between serum Se with dietary and other biochemical factors was adjusted for smoking, age and sex, and examined using general linear modelling. The validity of regression assumptions was tested by post hoc analysis to exclude significant heteroskedasticity and missing variable effects.

A serum Se concentration of about 100 μg/l has often been suggested to meet the physiological requirement for GPx(Reference Combs5, Reference Elsom, Sanderson and Hesketh30, Reference Rayman31); however, this threshold level may be as low as 80–90 μg/l(Reference Thomson32, Reference Xia, Hill and Byrne33). In the present study, we used both concentrations as cut-off points to assess the Se status of the population sample.

Due to the variation in response from different age and sex subgroups in the study sample, a population estimate was made that was weighted for age, sex and socio-economic status, using data from the 2006 Australian Census for this region.

Results

Subject characteristics

A total of 2545 people were contacted by letter, resulting in 520 positive responses (20 %); twenty-two subjects subsequently withdrew from the study. Response rates from the different age, sex and socio-economic status groups varied significantly (P < 0·001), resulting in a greater than expected proportion of women, older subjects and those with higher than average socio-economic status. The mean age of subjects was 57·4 (sd 12·3) years; 65 % of subjects were >55 years of age (Table 1). Mean BMI was 26·9 kg/m2; 62 % of subjects had a BMI >25 kg/m2 and 25 % had a BMI >30 kg/m2. A total of thirty-nine subjects were current smokers (male n 9 and female n 30).

Table 1 Anthropometric, dietary and biochemical indices of the study subjects

(Mean values and standard deviations)

GPx, glutathione peroxidase; TAS, total antioxidant status.

*  Variables were compared using general linear modelling.

1 U/l = 0·0167 μKat/l.

Regular consumption of multivitamin and mineral supplements was reported by 23 and 19 % of subjects, respectively. Only 8 % of subjects consumed supplements which contained Se.

Selenium intakes

Mean Se intake in men was 19 % higher than in women (P < 0·001); the difference was not statistically significant when expressed as intake per kg of body weight; however, women consumed significantly more Se per MJ of energy than men (P < 0·001; Table 1).

Se intakes did not vary significantly among the different age ranges in either sex (Table 2). The lowest Se intakes were observed in men aged 75–84 years and women aged 45–54 years. The highest Se intakes for both sexes were in younger age ranges: 35–44 years in men and 25–34 years in women. Significant differences in absolute intakes were observed between men and women aged 35–74 years (Table 2).

Table 2 Selenium intakes and serum selenium concentrations in age subgroups

(Mean values, standard deviations, medians, number of subjects and 95 % confidence intervals)

Mean values were significantly different from women in the age range of 75–84 years: * P = 0·017, **P = 0·021.

Comparisons were made between the age ranges in each sex and between the sexes in each age range using general linear modelling.

Mean Se intakes in current smokers were lower, but not significantly, than in non-smoking subjects (63·8 v. 70·4 μg/d; 95 % CI of difference − 5·1, 14·3; P = 0·352).

Similar proportions of men (28 %) and women (26 %) consumed less than the Australian estimated average requirement (60 and 50 μg/d, respectively)(34). The age range of 25–34 years had the lowest proportion of subjects consuming less than the estimated average requirement (18 %), while the three oldest age ranges (55–64, 65–74 and 75–84 years) had the highest proportions of subjects consuming below the estimated average requirement (29, 28 and 29 %, respectively).

Serum selenium

Mean serum Se concentration was 89·1 (sd 15·1) μg/l (range 45–178 μg/l); overall, there was no significant difference between men and women (Table 1). The lowest serum Se in both sexes was observed in subjects aged 75–84 years. The highest mean serum Se was observed in younger men aged 25–34 years, while women aged 55–64 and 65–74 years had the highest concentrations (Table 2). Comparisons between the age ranges were significant in women but not in men. Between-sex differences for each age range were only significant in the age range of 25–34 years (P = 0·024; Table 2).

Serum Se was lower in smokers compared with non-smokers (84·5 v. 89·3 μg/l; 95 % CI of difference 1·2, 8·4; P = 0·013), a difference that was reflected in serum GPx (847·3 v. 901·7 U/l; 95 % CI of difference 22·3, 110·6; P = 0·003).

Subjects who reported regular use of supplements containing Se had a mean serum Se nearly 10 % higher than non-users (97·0 v. 88·3 μg/l; 95 % CI of difference 3·1, 14·2; P = 0·002). Regular consumers of Brazil nuts (unspecified amount) also had a 15 % higher mean serum Se concentration compared with other subjects (103·0 v. 88·5 μg/l; 95 % CI of difference 5·3, 23·6; P = 0·002).

The distribution of serum Se concentrations is shown in Fig. 1; 83 % of subjects had serum Se concentrations below 100 μg/l, while 60 % of subjects had serum Se concentrations below 90 μg/l. Accordingly, serum Se concentration was observed to have a significant positive association with serum GPx activity (β = 1·5; P < 0·001), indicating that in many subjects, enzyme activity was dependent on serum Se concentrations.

Fig. 1 Frequency distribution (histogram), and cumulative proportion (lines) of sample () and adjusted population () estimates of serum Se in northern Tasmania. Dashed vertical lines indicate potential target concentrations (90 and 100 μg/l) for maximal glutathione peroxidase activity.

In the adjusted population estimates (Table 3), the prevalence of low Se intakes and serum Se levels below the threshold values was not significantly different compared with the study sample.

Table 3 Estimates of population proportions with intakes below the Australian/New Zealand estimated average requirement (EAR) and with serum selenium below potential thresholds associated with maximal glutathione peroxidase activity

(Mean values, standard deviations, proportions, 95 % confidence intervals and risk ratios)

*  Risk ratio was estimated by the Poisson regression adjusted for age, sex and socio-economic status.

Other associations

Serum Se had positive associations with serum HDL-cholesterol (β = 7·5; P < 0·001) and serum total cholesterol (β = 1·5; P = 0·014). Serum GPx activity was positively associated with serum HDL-cholesterol (β = 75·3; P < 0·001) and negatively associated with serum TAG (β = − 11·45; P = 0·038). Other factors associated with serum Se were body weight (β = − 0·1; P = 0·012), BMI (β = − 0·3; P = 0·008) and serum TAS (β = 8·5; P = 0·015).

Adjusted dietary intakes of Se (μg/kg per d) were positively associated with serum HDL-cholesterol (β = 0·16; P = 0·008) and negatively associated with serum TAG (β = − 0·33; P = 0·042).

Socio-economic status was not significantly associated with dietary intake estimates or biochemical markers of Se status.

Discussion

Selenium intakes

A quarter of all subjects reported intakes less than the estimated average requirement for Se. A much greater proportion had marginal serum Se concentrations, the proportion varying between 83 and 60 %, depending on the cut-off value that was used.

The discrepancy between the proportion of low Se intakes and low serum Se concentrations in the present study was potentially due to an overestimation of Se intakes arising from the use of Australian food content data(25), in the absence of Tasmanian data. As this database contains food content data from various sources, it cannot be truly representative of Tasmanian food content, leading to possible inaccuracies in intake estimations. In addition, even if validated for Se, the data collection method used, FFQ, has potential shortcomings, reviewed previously(Reference Byers35, Reference Kristal, Peters and Potter36), that may affect the accuracy of intake estimates.

Despite this, the estimates from the present study are the first reported for the Tasmanian population, and for men, these were considerably lower than the previously reported Australian intakes of 96(Reference Fardy, McOrist and Farrar37) and 89 μg/d(Reference Reilly38). In contrast, the estimates of 63(Reference Fardy, McOrist and Farrar37) and 59 μg/d(Reference Reilly38) for women from these two studies were similar to those for women in the present study. However, comparisons with these previous studies are problematic, as neither is recent and both have utilised direct food analysis of a representative diet rather than an FFQ used in the present study.

A significant influence on some subjects' Se intakes was Brazil nut consumption. The Se value of 920 μg/100 g in the food composition tables(25) shows the potential, as suggested previously(Reference Thomson, Chisholm and McLachlan39), to significantly increase Se intakes if consumed regularly. In the present study, the 3 % of subjects reporting regular intake of Brazil nuts had significantly higher serum Se than other subjects, with a mean above 100 μg/l.

Serum selenium

Given the strong positive association between serum Se and serum GPx activity, serum Se appears to be a more reliable indicator of Se status than dietary intakes in the present study.

The mean serum Se concentration was similar to the earlier published Tasmanian data of McGlashan et al. (Reference McGlashan, Cook and Melrose22) of 80·5 μg/l from 171 female blood donors, while a much smaller sample of blood donors in the study of Daniels(Reference Daniels, Gibson and Simmer24) had a mean serum Se concentration of 77·4 μg/l (n 25). Conversely, the most recent southern Tasmanian study of Jacobson et al. (Reference Jacobson, Tong and Townsend23) has reported a considerably higher mean plasma Se concentration of 109·8 μg/l. Although different sample types (plasma v. serum) and analytical methods (inductively coupled plasma MS v. graphite furnace atomic absorption spectroscopy) were utilised in these two studies, they are unlikely to result in such a large difference. However, significant differences in Se status have been observed between close geographical regions in the same country in other studies(Reference Arnaud, Bertrais and Roussel40Reference Thomson, McLachlan and Parnell42). Further research is required to determine whether this is also the case in Tasmania.

In comparison with the other Australian states, Se concentrations were similar between cohorts from South Australia(Reference Daniels, Gibson and Simmer24) and New South Wales(Reference Dhindsa, Bermingham and Mierzwa43) (87·6 and 91·6 μg/l, respectively) but lower in more recent Queensland(Reference Lymbury, Tinggi and Griffiths44) and South Australian(Reference Lyons, Judson and Stangoulis45) studies (100 and 102·6 μg/l, respectively).

The mean Se concentration observed in the present study was higher than that reported from the South Island of New Zealand (66·3–77·4 μg/l)(Reference Thomson41), a close geographical neighbour with well-described low Se status. It was, however, similar to many European countries, where Se intakes are marginal(Reference Rayman6), and much lower than countries such as the USA, Canada and Venezuela(Reference Rayman6) with high Se intakes.

In the present study, there were varying response rates in different population subgroups; however, our adjusted population estimates (Table 3) suggested that the results from this sample are reasonably representative of the population of northern Tasmania, and therefore marginal Se status could be prevalent in this population.

Effect of age, smoking and socio-economic status

The lowest mean serum Se concentrations were observed in the oldest age ranges. Declining Se status with age has previously been observed(Reference Brooks, Metter and Chan13, Reference Bates, Thane and Prentice46) and could be particularly important in populations with already marginal Se status, where it may contribute to a decline in health in older people, particularly considering its role in immune(Reference Broome, McArdle and Kyle3) and antioxidant defence systems(Reference Moghadaszadeh and Beggs1).

Smoking has also been associated with lower Se status in previous studies(Reference Kafai and Ganji47Reference McLachlan, Thomson and Ferguson49); this may be because of decreased Se intake or an increased demand for Se due to increased oxidative stress from exposure to cigarette smoke. The cause of lower Se status in smokers in the present study seems at least partly related to a decreased Se intake, even though the relatively large intake differences between smokers and non-smokers were not statistically significant.

Observations of associations between higher socio-economic status and healthier diets have been made in Australia and elsewhere(Reference Beydoun and Wang50, Reference Giskes, Turrell and Patterson51); however, in the present study, socio-economic status (as measured by the SEIFA index) did not appear to be a significant factor influencing Se status. This lack of association with Se status is consistent with the observations in recent Tasmanian(Reference Jacobson, Tong and Townsend23) and French studies(Reference Arnaud, Bertrais and Roussel40) but is in contrast to some findings in Britain(Reference Bates, Thane and Prentice46, Reference Bates, Thane and Prentice52).

Other associations with selenium

To date, findings regarding the relationship between the various indices of Se status and cardiovascular risk factors have been inconsistent. Several studies have reported positive associations between Se and serum lipids(Reference Suadicani, Hein and Gyntelberg53Reference Stranges, Laclaustra and Ji57), including each of serum total cholesterol, HDL-cholesterol, LDL-cholesterol and TAG(Reference Bleys, Navas-Acien and Stranges56), while others have found no association(Reference Ghayour-Mobarhan, Taylor and New58). In the present study, serum Se and serum GPx had modest associations with several lipid measures, as well as with body weight and BMI. The mechanisms for such associations with serum lipids are unknown; these may be due to the effects of selenoproteins such as GPx or iodothyronine deiodinase on lipid metabolism or simply the result of inter-related dietary exposures, as has been proposed previously(Reference Bleys, Navas-Acien and Stranges56); the latter could explain the significant associations found in the present study between intakes adjusted for energy and serum lipid components.

Serum TAS is a non-specific measure of antioxidant status. It was measured to determine whether any subgroups within the population sample had a different antioxidant status, and whether this was related to Se status. The sex differences observed in TAS have previously been reported(Reference Wang, Rainwater and VandeBerg59), but TAS did not vary significantly in other groups, such as smokers. This could fit with the suggestion(Reference Wang, Rainwater and VandeBerg59) that up to 50 % of the variation in TAS results from additive genetic differences. Serum TAS in this sample was significantly associated with serum Se but not with GPx.

Chronic Se toxicity is thought to only occur at concentrations over 500 μg/l(Reference Nuttall60); the highest 5 % of Se concentrations in northern Tasmania was 113–178 μg/l. Recent studies reporting associations between higher Se status and higher lipid levels(Reference Bleys, Navas-Acien and Stranges56, Reference Stranges, Laclaustra and Ji57) and also increased diabetes risk(Reference Lippman, Klein and Goodman20, Reference Bleys, Navas-Acien and Guallar61, Reference Stranges, Marshall and Natarajan62) have prompted some concern over the potential adverse effects of increasing Se intakes, particularly in Se-replete populations, although the basis of such relationships remains unclear. Se concentrations in most of these studies are considerably higher than those observed in the present study, except the UK study of Stranges et al. (Reference Stranges, Laclaustra and Ji57).

Conclusion

The major finding from the present study was that a significant proportion of the northern Tasmanian population had Se concentrations below the physiological requirement for Se, regardless of which cut-off value was used. Furthermore, almost the entire sample (97 %) had Se levels below 119 μg/l, which has been suggested as a target for maximising the chemopreventive effect of Se(Reference Combs5).

With the importance of Se in many facets of health, including possible roles in the prevention of cancer and CVD, major burdens on health systems and particular concerns in the Tasmanian population(63), an increase in Se intakes could provide significant health benefits. However, due to the recent concern over the potential adverse effects of higher Se intakes, further large-scale studies in populations with marginal Se status, such as the long-proposed Prevention of Cancer by Intervention with Selenium (PRECISE) trial(Reference Rayman31), are required before current recommended intakes are increased.

Acknowledgements

The present study was supported by a research grant from the Clifford Craig Medical Research Trust (Launceston, TAS, Australia). The authors wish to thank the Launceston General Hospital Pathology Department (Launceston, TAS, Australia), the NorthWest Pathology (Burnie, TAS, Australia), the Scottsdale Doctors Surgery (Scottsdale, TAS, Australia), the Campbell Town Health and Community Centre (Campbell Town, TAS, Australia) for their assistance in blood collection and the Royal Hobart Hospital Pathology Department (Hobart, TAS, Australia) for assistance with specimen analysis. Dr Iain Robertson, consultant biostatistician, assisted with the sample determination from the electoral roll and biostatistical analysis. J. M. B. designed the study, recruited the subjects, performed the dietary, biochemical and statistical analyses, and wrote the manuscript. M. J. B. designed the study, discussed the data, corrected the manuscript and provided significant advice throughout. Neither author had a conflict of interest.

References

1Moghadaszadeh, B & Beggs, AH (2006) Selenoproteins and their impact on human health through diverse physiological pathways. Physiology 21, 307315.Google Scholar
2Reeves, MA & Hoffmann, PR (2009) The human selenoproteome: recent insights into functions and regulation. Cell Mol Life Sci 66, 24572478.CrossRefGoogle ScholarPubMed
3Broome, CS, McArdle, F, Kyle, JA, et al. (2004) An increase in selenium intake improves immune function and poliovirus handling in adults with marginal selenium status. Am J Clin Nutr 80, 154162.CrossRefGoogle ScholarPubMed
4Curran, JE, Jowett, JB, Elliott, KS, et al. (2005) Genetic variation in selenoprotein S influences inflammatory response. Nat Genet 37, 12341241.CrossRefGoogle ScholarPubMed
5Combs, GF Jr (2001) Selenium in global food systems. Br J Nutr 85, 517547.CrossRefGoogle ScholarPubMed
6Rayman, MP (2008) Food-chain selenium and human health: emphasis on intake. Br J Nutr 100, 254268.CrossRefGoogle ScholarPubMed
7Clark, LC, Cantor, KP & Allaway, WH (1991) Selenium in forage crops and cancer mortality in U.S. counties. Arch Environ Health 46, 3742.CrossRefGoogle ScholarPubMed
8Kneller, RW, Guo, WD, Hsing, AW, et al. (1992) Risk factors for stomach cancer in sixty-five chinese counties. Cancer Epidemiol Biomarkers Prev 1, 113118.Google ScholarPubMed
9Wei, WQ, Abnet, CC, Qiao, YL, et al. (2004) Prospective study of serum selenium concentrations and esophageal and gastric cancer, heart disease, stroke and total death. Am J Clin Nutr 79, 8085.CrossRefGoogle ScholarPubMed
10Duffield-Lillico, AJ, Reid, ME, Turnbull, BW, et al. (2002) Baseline characteristics and the effect of selenium supplementation on cancer incidence in a randomized clinical trial: a summary report of the Nutritional Prevention of Cancer Trial. Cancer Epidemiol Biomarkers Prev 11, 630639.Google Scholar
11Yoshizawa, K, Willett, WC, Morris, SJ, et al. (1998) Study of prediagnostic selenium level in toenails and the risk of advanced prostate cancer. J Natl Cancer Inst 90, 12191224.Google Scholar
12Nomura, AM, Lee, J, Stemmermann, GN, et al. (2000) Serum selenium and subsequent risk of prostate cancer. Cancer Epidemiol Biomarkers Prev 9, 883887.Google Scholar
13Brooks, JD, Metter, EJ, Chan, DW, et al. (2001) Plasma selenium level before diagnosis and the risk of prostate cancer development. J Urol 166, 20342038.CrossRefGoogle ScholarPubMed
14Rudolph, RE, Vaughan, TL, Kristal, AR, et al. (2003) Serum selenium levels in relation to markers of neoplastic progression among persons with Barrett's esophagus. J Natl Cancer Inst 95, 750757.CrossRefGoogle ScholarPubMed
15Kellen, E, Zeegers, M & Buntinx, F (2006) Selenium is inversely associated with bladder cancer risk: a report from the Belgium case–control study on bladder cancer. Int J Urol 13, 11801184.Google Scholar
16Mark, SD, Qiao, YL, Dawsey, SM, et al. (2000) Prospective study of serum selenium levels and incident esophageal and gastric cancers. J Natl Cancer Inst 92, 17531763.CrossRefGoogle ScholarPubMed
17Mannisto, S, Alfthan, G, Virtanen, M, et al. (2000) Toenail selenium and breast cancer – a case–control study in Finland. Eur J Clin Nutr 54, 98103.CrossRefGoogle ScholarPubMed
18Thompson, FE, Patterson, BH, Weinstein, SJ, et al. (2002) Serum selenium and the risk of cervical cancer among women in the United States. Cancer Causes Control 13, 517526.CrossRefGoogle ScholarPubMed
19Wallace, K, Byers, T, Morris, JS, et al. (2003) Prediagnostic serum selenium concentration and the risk of recurrent colorectal adenoma: a nested case–control study. Cancer Epidemiol Biomarkers Prev 12, 464467.Google ScholarPubMed
20Lippman, SM, Klein, EA, Goodman, PJ, et al. (2009) Effect of selenium and vitamin E on risk of prostate cancer and other cancers: the Selenium and Vitamin E Cancer Prevention Trial (SELECT). JAMA 301, 3951.CrossRefGoogle Scholar
21Mason, RW (2007) Iodine deficiency in grazing livestock in Tasmania. In Goitre Monitor – The History of Iodine Deficiency in Tasmania, pp. 239253 [Richards, PAC and Stewart, JC, editors]. Launceston: Myola House of Publishing.Google Scholar
22McGlashan, ND, Cook, SJ, Melrose, W, et al. (1996) Maternal selenium levels and sudden infant death syndrome (SIDS). Aust N Z J Med 26, 677682.Google Scholar
23Jacobson, GA, Tong, YC, Townsend, AT, et al. (2007) Selenium status in southern Tasmania. Eur J Clin Nutr 61, 10571063.Google Scholar
24Daniels, LA, Gibson, RA & Simmer, KN (2000) Indicators of selenium status in Australian infants. J Paediatr Child Health 36, 370374.CrossRefGoogle ScholarPubMed
25FSANZ (2006) NUTTAB 2006: Australian Food Composition Tables. Canberra: Food Standards Australia New Zealand.Google Scholar
26A.B.S. (2006) Socio-economic Indexes for Areas (SEIFA) – Technical Paper (ABS Cat. No. 2039.0.55.001). Canberra: Australian Bureau of Statistics.Google Scholar
27Saeed, K, Thomassen, Y & Langmyhr, FJ (1979) Direct electrothermal atomic absorption spectrometric determination of selenium in serum. Anal Chim Acta 110, 285289.CrossRefGoogle Scholar
28Paglia, DE & Valentine, WN (1967) Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J Lab Clin Med 70, 158169.Google ScholarPubMed
29Aickin, M & Gensler, H (1996) Adjusting for multiple testing when reporting research results: the Bonferroni vs Holm methods. Am J Public Health 86, 726728.CrossRefGoogle ScholarPubMed
30Elsom, R, Sanderson, P, Hesketh, JE, et al. (2006) Functional markers of selenium status: UK Food Standards Agency workshop report. Br J Nutr 96, 980984.CrossRefGoogle ScholarPubMed
31Rayman, MP (2000) The importance of selenium to human health. Lancet 356, 233241.CrossRefGoogle ScholarPubMed
32Thomson, CD (2004) Assessment of requirements for selenium and adequacy of selenium status: a review. Eur J Clin Nutr 58, 391402.CrossRefGoogle ScholarPubMed
33Xia, Y, Hill, KE, Byrne, DW, et al. (2005) Effectiveness of selenium supplements in a low-selenium area of China. Am J Clin Nutr 81, 829834.CrossRefGoogle Scholar
34NHMRC (2006) Nutrient Reference Values for Australia and New Zealand. Canberra: National Health and Medical Research Council.Google Scholar
35Byers, T (2001) Food frequency dietary assessment: how bad is good enough? Am J Epidemiol 154, 10871088.Google Scholar
36Kristal, AR, Peters, U & Potter, JD (2005) Is it time to abandon the food frequency questionnaire? Cancer Epidemiol Biomarkers Prev 14, 28262828.Google Scholar
37Fardy, JJ, McOrist, GD & Farrar, YJ (1989) The determination of selenium status in the Australian diet using neutron activation analysis. J Radioanal Nucl Chem 133, 397405.Google Scholar
38Reilly, C (1992) Selenium in Australian health and disease. Proc Nutr Soc Aust 17, 109114.Google Scholar
39Thomson, CD, Chisholm, A, McLachlan, SK, et al. (2008) Brazil nuts: an effective way to improve selenium status. Am J Clin Nutr 87, 379384.Google Scholar
40Arnaud, J, Bertrais, S, Roussel, AM, et al. (2006) Serum selenium determinants in French adults: the SU.VI.M.AX study. Br J Nutr 95, 313320.Google Scholar
41Thomson, CD (2004) Selenium and iodine intakes and status in New Zealand and Australia. Br J Nutr 91, 661672.CrossRefGoogle Scholar
42Thomson, CD, McLachlan, SK, Parnell, WR, et al. (2007) Serum selenium concentrations and dietary selenium intake of New Zealand children aged 5–14 years. Br J Nutr 97, 357364.CrossRefGoogle ScholarPubMed
43Dhindsa, HS, Bermingham, MA, Mierzwa, J, et al. (1998) Plasma selenium concentrations in a Sikh population in Sydney, Australia. Analyst 123, 885887.Google Scholar
44Lymbury, R, Tinggi, U, Griffiths, L, et al. (2008) Selenium status of the Australian population: effect of age, gender and cardiovascular disease. Biol Trace Elem Res 126, S1S10.CrossRefGoogle ScholarPubMed
45Lyons, GH, Judson, GJ, Stangoulis, JC, et al. (2004) Trends in selenium status of South Australians. Med J Aust 180, 383386.CrossRefGoogle ScholarPubMed
46Bates, CJ, Thane, CW, Prentice, A, et al. (2002) Selenium status and its correlates in a British national diet and nutrition survey: people aged 65 years and over. J Trace Elem Med Biol 16, 18.CrossRefGoogle Scholar
47Kafai, MR & Ganji, V (2003) Sex, age, geographical location, smoking, and alcohol consumption influence serum selenium concentrations in the USA: third National Health and Nutrition Examination Survey, 1988–1994. J Trace Elem Med Biol 17, 1318.CrossRefGoogle ScholarPubMed
48Galan, P, Viteri, FE, Bertrais, S, et al. (2005) Serum concentrations of beta-carotene, vitamins C and E, zinc and selenium are influenced by sex, age, diet, smoking status, alcohol consumption and corpulence in a general French adult population. Eur J Clin Nutr 59, 11811190.Google Scholar
49McLachlan, SK, Thomson, CD, Ferguson, EL, et al. (2004) Dietary and biochemical selenium status of urban 6- to 24-month-old South Island New Zealand children and their postpartum mothers. J Nutr 134, 32903295.CrossRefGoogle ScholarPubMed
50Beydoun, MA & Wang, Y (2008) How do socio-economic status, perceived economic barriers and nutritional benefits affect quality of dietary intake among US adults? Eur J Clin Nutr 62, 303313.Google Scholar
51Giskes, K, Turrell, G, Patterson, C, et al. (2002) Socio-economic differences in fruit and vegetable consumption among Australian adolescents and adults. Public Health Nutr 5, 663669.Google Scholar
52Bates, CJ, Thane, CW, Prentice, A, et al. (2002) Selenium status and associated factors in a British National Diet and Nutrition Survey: young people aged 4–18 y. Eur J Clin Nutr 56, 873881.CrossRefGoogle Scholar
53Suadicani, P, Hein, HO & Gyntelberg, F (1992) Serum selenium concentration and risk of ischaemic heart disease in a prospective cohort study of 3000 males. Atherosclerosis 96, 3342.CrossRefGoogle Scholar
54Gamez, C, Ruiz-Lopez, D, Artacho, R, et al. (1997) Serum selenium in institutionalized elderly subjects and relation to other nutritional markers. Clin Chem 43, 693694.CrossRefGoogle ScholarPubMed
55Hercberg, S, Bertrais, S, Czernichow, S, et al. (2005) Alterations of the lipid profile after 7.5 years of low-dose antioxidant supplementation in the SU.VI.MAX study. Lipids 40, 335342.Google Scholar
56Bleys, J, Navas-Acien, A, Stranges, S, et al. (2008) Serum selenium and serum lipids in US adults. Am J Clin Nutr 88, 416423.Google Scholar
57Stranges, S, Laclaustra, M, Ji, C, et al. (2009) Higher selenium status is associated with adverse blood lipid profile in British adults. J Nutr 140, 8187.Google Scholar
58Ghayour-Mobarhan, M, Taylor, A, New, SA, et al. (2005) Determinants of serum copper, zinc and selenium in healthy subjects. Ann Clin Biochem 42, 364375.CrossRefGoogle ScholarPubMed
59Wang, XL, Rainwater, DL, VandeBerg, JF, et al. (2001) Genetic contributions to plasma total antioxidant activity. Arterioscler Thromb Vasc Biol 21, 11901195.Google Scholar
60Nuttall, KL (2006) Evaluating selenium poisoning. Ann Clin Lab Sci 36, 409420.Google ScholarPubMed
61Bleys, J, Navas-Acien, A & Guallar, E (2007) Serum selenium and diabetes in U.S. adults. Diabetes Care 30, 829834.Google Scholar
62Stranges, S, Marshall, JR, Natarajan, R, et al. (2007) Effects of long-term selenium supplementation on the incidence of type 2 diabetes: a randomized trial. Ann Intern Med 147, 217223.CrossRefGoogle ScholarPubMed
63A.B.S. (2006) National Health Survey: Summary of Results (2004–2005) (ABS Cat. No. 4364.0). Canberra: Australian Bureau of Statistics.Google Scholar
Figure 0

Table 1 Anthropometric, dietary and biochemical indices of the study subjects(Mean values and standard deviations)

Figure 1

Table 2 Selenium intakes and serum selenium concentrations in age subgroups†(Mean values, standard deviations, medians, number of subjects and 95 % confidence intervals)

Figure 2

Fig. 1 Frequency distribution (histogram), and cumulative proportion (lines) of sample () and adjusted population () estimates of serum Se in northern Tasmania. Dashed vertical lines indicate potential target concentrations (90 and 100 μg/l) for maximal glutathione peroxidase activity.

Figure 3

Table 3 Estimates of population proportions with intakes below the Australian/New Zealand estimated average requirement (EAR) and with serum selenium below potential thresholds associated with maximal glutathione peroxidase activity(Mean values, standard deviations, proportions, 95 % confidence intervals and risk ratios)